Google is licensing its diabetic retinopathy AI model to healthcare providers and healthtech partners, including Forus Health, Aurolab, and Perceptra, to broaden the tool’s reach across India and Thailand, with the goal of improving outcomes for diabetic patients.
These partners will focus on securing local regulatory approvals to integrate the model into clinical care systems in both countries. Over the next decade, they aim to provide a combined 6 million AI-supported screenings to resource-constrained communities, free of charge for patients.
Additionally, the tech giant is collaborating with the Thai Ministry of Public Health’s Department of Medical Services, which oversees the country’s diabetic retinopathy screening programme, on implementation research and cost-effectiveness analysis.
Matt is an award-winning storyteller, writer, and communicator currently based in Riyadh.
A native Englishman, his career has led him to diverse locations including China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE.
In addition to founding HealthTechAsia, Matt is a co-founder of the non-profit Pul Alliance for Digital Health and Equity.
In a former life, he oversaw editorial coverage for Arab Health, Asia Health, Africa Health, and other key events.
In 2021, he won a Medical Travel Media Award, organised by Malaysia Healthcare Travel Council, and a Guardian Student Media Award in 2000.
Matt is an award-winning storyteller, writer, and communicator currently based in Riyadh.
A native Englishman, his career has led him to diverse locations including China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE.
In addition to founding HealthTechAsia, Matt is a co-founder of the non-profit Pul Alliance for Digital Health and Equity.
In a former life, he oversaw editorial coverage for Arab Health, Asia Health, Africa Health, and other key events.
In 2021, he won a Medical Travel Media Award, organised by Malaysia Healthcare Travel Council, and a Guardian Student Media Award in 2000.